Family Medicine · N Ridgeville, OH
NPI
1073725396
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6115 Emerald St
N Ridgeville, OH, 44039
Phone (440) 327-7372
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
5,701 services
Medicare patients, 2024
387
Average age 74
Drug cost, 2024
$1.5M
18,064 prescriptions
Company payments, 2025
$2,261
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank M Hiti was code 99213 (office e&m - established), 699 times for 359 patients. In total Frank M Hiti billed 5,701 services in 28 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 699 | 359 | $26.22 | $18K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 271 | 271 | $46.73 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 157 | 125 | $12.12 | $1,904 |
| 99214 Office E&M - Established | Office | 141 | 115 | $39.75 | $5,604 |
| G0008 Administration of influenza virus vaccine | Office | 62 | 61 | $30.40 | $1,885 |
| 90662 Vaccine Product | Office | 55 | 54 | $65.66 | $3,611 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 32 | 25 | $57.43 | $1,838 |
| 81003 Clinical Chemistry | Office | 31 | 22 | $2.20 | $68.2 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 30 | 23 | $36.46 | $1,094 |
| 93000 Electrocardiogram | Office | 16 | 16 | $6.78 | $108 |
| 99212 Office E&M - Established | Office | 14 | 11 | $22.60 | $316 |
By year: 2022 $66K for 14,695 services; 2023 $56K for 5,402 services; 2024 $51K for 5,701 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 31 | 22 | $2.20 | $68.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Frank M Hiti prescribed most often to Medicare patients was Levothyroxine Sodium, with 635 prescriptions and refills. In total Frank M Hiti wrote 18,064 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 635 | 1,484 | 170 | $5,086 |
| Atorvastatin Calcium Generic | 599 | 1,591 | 192 | $5,878 |
| Pantoprazole Sodium Generic | 509 | 1,122 | 153 | $6,488 |
| Amlodipine Besylate Generic | 490 | 1,273 | 146 | $2,272 |
| Benazepril Hcl Generic | 490 | 1,229 | 131 | $5,064 |
| Diclofenac Sodium Generic | 415 | 751 | 119 | $6,523 |
| Gabapentin Generic | 411 | 662 | 97 | $5,819 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 407 | 407 | 69 | $13K |
| Simvastatin Generic | 372 | 1,017 | 105 | $2,790 |
| Rosuvastatin Calcium Generic | 350 | 900 | 113 | $4,757 |
| Citalopram Hbr Citalopram Hydrobromide | 342 | 719 | 95 | $2,241 |
| Metformin Hcl Generic | 341 | 879 | 101 | $1,866 |
| Omeprazole Generic | 340 | 807 | 105 | $4,328 |
| Hydrochlorothiazide Generic | 303 | 749 | 100 | $1,157 |
| Metoprolol Succinate Generic | 284 | 751 | 93 | $4,446 |
Brand drugs: 1,870 claims; generic drugs: 16,157 claims; opioid claims: 936.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank M Hiti $2,261 ($2,261 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $390.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $390 |
| Pfizer Inc. PFE | 15 | $255 |
| Abbvie Inc. ABBV | 15 | $241 |
| GlaxoSmithKline, LLC. GSK | 9 | $171 |
| Novo Nordisk Inc NVO | 11 | $170 |
| Axsome Therapeutics, Inc. AXSM | 7 | $149 |
| Lilly USA, LLC LLY | 8 | $147 |
| Phathom Pharmaceuticals, Inc. PHAT | 15 | $135 |
| Abbott Laboratories ABT | 6 | $102 |
| Astellas Pharma US Inc 4503.T | 4 | $78.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.